Navigation Links
China MMR Vaccine Market 2013 Analysis and 2017 Forecasts in New Research Report at ChinaMarketResearchReports.com
Date:9/26/2013

Dallas, TX (PRWEB) September 27, 2013

Measles, mumps and rubella are major infectious diseases that threaten the health of children. Measles is a kind of acute respiratory infectious disease caused by measles virus with rashes covering the whole body. Mumps is a kind of respiratory infectious disease caused by mumps virus, which can violate organs including various gland tissues, nervous system, liver, kidney, heart, joint, etc. Rubella is a kind of acute respiratory infectious disease caused by rubella virus with light constitutional symptoms and lymphadenectasis behind the ears and on the necks, without koplik spots.

Complete report is available @ http://www.chinamarketresearchreports.com/114625.html.

In China, the incidence rate of measles declines constantly in recent years. In 2012, the number of measles patients was 6,183, decreasing by 37.82% YOY, with eight patients died of measles. In 2012, the incidence rate of measles was 4.6/100,000,000, which still lagged far behind the target set by WHO (incidence rate: below 1/100,000,000). In 2012, China’s lot released volume of measles vaccines reached 8.651 million personservings, decreasing by 43.5% YOY.

From 2010 to 2012, China’s incidence rate of mumps increased year after year. In 2012, the number of mumps patients was 479,518, increasing by 5.53% YOY; the incidence rate was 354.1/100,000,000 without any death. In 2012, China’s lot released volume of mumps vaccines was about 6.883 million personservings, decreasing by 47% YOY.

In 2012, the number of rubella patients was 40,156 in China, decreasing by 38.74% YOY; the incidence rate was 29.7/100,000,000 and one patient died. In 2012, China’s lot released volume of rubella vaccines was about 4.44 million personservings, decreasing by 6.4% YOY.

Since domestic MMR vaccines were listed in China National Immunization Program in 2008, Chinese government has been providing eligible children with free MMR vaccines. If parents require imported MMR vaccines, it will at their own expenses.

According to longterm trend, MMR vaccines will gradually replace univalent vaccines or bivalent vaccines, becoming the mainstream in the market. During 2010 to 2012, China’s lot released volume of MMR vaccines slightly declined, which mainly resulted from the fact that imported MMR vaccines were restricted. Along with the implementation of Pharmacopoeia of China (2010 Version), CFDA has not approved the MMR vaccine of GSK to be sold in China because it contains antibiotics. In 2011, a Chinese law office revealed that the MMR vaccines manufactured by Merck violated the approval process of imported vaccines in China because it lacked alerts in the specification and existed safety risks. During 2011 to 2012, China’s legal import volume of MMR vaccines decreased sharply. As a result, China’s total lot released volume of MMR vaccines also decreased to some extent.

In recent years, because China’s newborn population is 16 million or even more every year, the prospect of MMR vaccines is promising. Although the import of MMR vaccines is restricted in China, many parents still choose imported MMR vaccines for their children out of the safety concern on domestic vaccines. These imported MMR vaccines are sold in some private clinics, which may come from smuggling.

Purchase a copy of this report @ http://www.chinamarketresearchreports.com/contacts/purchase.php?name=114625.

About Us:

ChinaMarketResearchReports.com (http://www.chinamarketresearchreports.com/) is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.

Read the full story at http://www.prweb.com/releases/china-measles-mumps/rubella-vaccine-market/prweb11165509.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. The Changing Face of Cervical Cancer in China
2. China Varicella Vaccine Market Discussed in In-demand QYResearch Report Published at MarketPublishers.com
3. China Haemophilus Influenza B (HIB) Vaccine Market 2017 Forecasts in New Research Now Available at MarketReportsOnline.com
4. Perfume Industry Review of Natural & Synthetic Perfumes for Global & China Markets in a New Research Study Available at DeepResearchReports.com
5. China Non-Small Cell Lung Cancer Analysis & 2022 Forecasts in New Research Report at RnRMarketResearch.com
6. China Human Rabies Vaccine Industry 2013 Analysis & 2017 Forecasts in New Research Report at RnRMarketResearch.com
7. 2013 China Medical Insurance Inflation Rates Revealed
8. China Poultry Vaccine Market Analysis
9. China Orthopedic Instrument Market 2013 Analysis & 2015 Forecasts in New Research Report at RnRMarketResearch.com
10. Medical Device Manufacturing in China Industry Research Report – Now Available from IBISWorld
11. China Independent Clinical Laboratory Industry Report, 2013-2015: Worldwide Industry Latest Market Share, Strategy, Growth, Size, Trends and Forecast Research Report 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... ... 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida ... their peers for this recognition are considered among the top 2 percent of lawyers ... as members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon and the ... in the world, and the most handsome men, look naturally attractive. Plastic surgery ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the placement ... Vice President of North American Capital Sales at HTG Molecular . ... in the commercialization of the HTG EdgeSeq system and associated reagents in North America. ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Any dentist who has made ... the current process. Many of them do not even offer ... difficulties and high laboratory costs involved. And those who ARE ... at such a high cost that the majority of today,s ... Dr. Parsa Zadeh , founder of Dental Evolutions Inc. ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
Breaking Medicine Technology: